Brooke M. Katzman, Ph.D.

  1. Kroner GM, Katzman BM, Chambliss AB, Conta JH, Dickerson JA. Promoting Health Equity Through Effective Laboratory Stewardship Strategies. Clin Lab Med. 2024 Dec; 44 (4):665-677 Epub 2024 Aug 16
    View PubMed
  2. Katzman BM, Wockenfus AM, Kelley BR, Karon BS, Donato LJ. Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test. Clin Biochem. 2023 Jul; 117:1-3 Epub 2021 Nov 17
    View PubMed
  3. Katzman B, Baumann NA. Investigating immunoassay interferences: polish your troubleshooting tools and avoid the red herring. Clinical Laboratory News. 2022; 48(3):4-5.
  4. Donato LJ, Wockenfus AM, Katzman BM, Baumann NA, Jaffe AS, Karon BS. Analytical and Clinical Considerations in Implementing the Roche Elecsys Troponin T Gen 5 STAT Assay. Am J Clin Pathol. 2021 Nov 8; 156 (6):1121-1129
    View PubMed
  5. Katzman BM, Karon BS. Test Utilization Proposal for Reflex Bilirubin Testing: Why Order Two Tests When One Will Do? J Appl Lab Med. 2021 Jul 7; 6 (4):980-984
    View PubMed
  6. Katzman BM, Hain EA, Donato LJ, Baumann NA. Validation of a Commercial Reagent for the Depletion of Biotin from Serum/Plasma: A Rapid and Simple Tool to Detect Biotin Interference with Immunoassay Testing. J Appl Lab Med. 2021 Jul 7; 6 (4):992-997
    View PubMed
  7. Katzman BM, Kelley BR, Deobald GR, Myhre NK, Agger SA, Karon BS. Unintended Consequence of High-Dose Vitamin C Therapy for an Oncology Patient: Evaluation of Ascorbic Acid Interference With Three Hospital-Use Glucose Meters. J Diabetes Sci Technol. 2021 Jul; 15 (4):897-900 Epub 2020 June 07
    View PubMed
  8. Katzman BM, Bryant SC, Karon BS. Is It Time to Remove Total Calcium from the Basic and Comprehensive Metabolic Panels? Assessing the Effects of American Medical Association-Approved Chemical Test Panels on Laboratory Utilization. Clin Chem. 2020 Nov 1; 66 (11):1444-1449
    View PubMed
  9. Bowen R, Benavides R, Colon-Franco JM, Katzman BM, Muthukumar A, Sadrzadeh H, Straseski J, Klause U, Tran N. Best practices in mitigating the risk of biotin interference with laboratory testing. Clin Biochem. 2019 Dec; 74:1-11 Epub 2019 Aug 29
    View PubMed
  10. Katzman BM, Wockenfus AM, Scott RJ, Bryant SC, Jaffe AS, Karon BS. Estimating short- and long-term reference change values and index of individuality for tests of platelet function. Clin Biochem. 2019 Dec; 74:54-59 Epub 2019 Nov 04
    View PubMed
  11. Summerfield DD, Hartung KJ, Wiese CR, Wockenfus AM, Katzman BM, Donato LJ, Karon BS. Relationship between free hemoglobin (hemolysis), potassium and ionized calcium in lithium heparin blood gas samples collected intraoperatively. Clin Biochem. 2019 Aug; 70:46-48 Epub 2019 May 03
    View PubMed
  12. Katzman BM, Cox BD, Prosser AR, Alcaraz AA, Murat B, Heroux M, Tebben A, Zhang Y, Schroeder GM, Snyder JP, Wilson LJ, Liotta DC. Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor. ACS Med Chem Lett. 2019 Jan 10; 10 (1):67-73 Epub 2018 Nov 30
    View PubMed
  13. Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem. 2018 Sep; 60:11-16 Epub 2018 July 21
    View PubMed
  14. Stieglitz HM, Korpi-Steiner N, Katzman B, Mersereau JE, Styner M. Suspected Testosterone-Producing Tumor in a Patient Taking Biotin Supplements. J Endocr Soc. 2018 Jun 1; 2 (6):563-569 Epub 2018 May 10
    View PubMed
  15. Huang MB, Giesler KG, Katzman BM, Prosser AR, Truax V, Liotta DC, Wilson LJ, Bond VC. Small Molecule CXCR4 Antagonists Block the HIV-1 Nef/CXCR4 Axis and Selectively Initiate the Apoptotic Program in Breast Cancer Cells Oncotarget. 2018; 9(24):16996-17013.
  16. Perszyk R, Katzman BM, Kusumoto H, Kell SA, Tahirovic YA, Moore RL, Menaldino D, Burger P, Liotta DC, Traynelis SF. An NMDAR Positive and Negative Allosteric Modulator Series Share a Binding Site and are Interconverted by Methyl Groups eLife, ASAP. 2018.
  17. Jecs E, Miller EJ, Wilson RJ, Nguyen HH, Tahirovic YA, Katzman BM, Truax VM, Kim MB, Kuo KM, Wang T, Sum CS, Cvijic ME, Schroeder GM, Wilson LJ, Liotta DC. Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-Chains. ACS Med Chem Lett. 2018 Feb 8; 9 (2):89-93 Epub 2017 Dec 20
    View PubMed
  18. Miller EJ, Jecs E, Truax VM, Katzman BM, Tohirovic YA, Wilson RJ, Kuo KM, Kim MB, Nyguyen HH, Saindane MT, Zhao H, Wang T, Sum CS, Cvijic ME, Schroeder GM, Wilson LJ, Liotta DC. Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properrties Journal of Medicinal Chemistry. 2018; 61(3):946-979.
  19. Katzman BM, Ness KM, Algeciras-Schimnich A. Evaluation of the CLSI EP26-A protocol for detection of reagent lot-to-lot differences. Clin Biochem. 2017 Sep; 50 (13-14):768-771 Epub 2017 Mar 18
    View PubMed
  20. Katzman BM, Perszyk RE, Yuan H, Tahirovic Atlas, Sotimehin AE, Traynelis SF, Liotta DC. Synthesis and Structure Activity Relationship of a Novel Class of Thiophene-Based Negative Allosteric Modulators of N-Methyl-D-Aspartate Receptors Bioorganic Med Chem Letters. 2015; 25(23):5583-5588.
  21. Cox BD, Prosser AR, Katzman BM, Alcaraz AA, Liotta DC, Wilson LJ, Snyder JP. Anti-HIV small-molecule binding in the Peptide subpocket of the CXCR4:CVX15 crystal structure ChemBio Chem. 2014; 15(11):1614-1620.
  22. Truax VM, Zhao H, Katzman BM, Prosser AR, Alcaraz AA, Saindane MT, Howard RB, Culver D, Arrendale RF, Gruddanti PR, Evers TJ, Natchus MG, Snyder JP, Liotta DC, Wilson LJ. Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists ACS Medicinal Chemistry Letters. 2013; 4(12):1025-1030. Epub 2013 Nov 04.
  23. Santangelo RM, Acker TM, Zimmerman SS, Katzman BM, Strong KL, Traynelis SF, Liotta DC. Novel NMDA receptor modulators: An update Expert Opionion on Therapeutic Pattents. 2012; 22(11):1337-1352. Epub 2012 Sep 26.